A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment

Tumor microenvironment differences between primary tumor and brain metastases

(2020) Bernardo Cacho-Díaz et al.   Journal of Translational Medicine

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

(2020) Eva Schrezenmeier et al.   Nature Reviews Rheumatology

ICU-acquired weakness, diaphragm dysfunction and long-term outcomes of critically ill patients

(2020) Clément Saccheri et al.   Annals of Intensive Care

Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19

(2020) Yang Wang et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection

(2020) David N. Juurlink   CANADIAN MEDICAL ASSOCIATION JOURNAL

The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection

(2020) Moussa Saleh et al.   Circulation-Arrhythmia and Electrophysiology

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19

(2020) S. Gevers et al.   CLINICAL MICROBIOLOGY AND INFECTION

Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy)

(2020) Elisa Maria Stroppa et al.   Future Oncology

QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin

(2020) Ehud Chorin et al.   HEART RHYTHM

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

(2020) Lisheng Wang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

(2020) Philippe Gautret et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

(2020) Eli S. Rosenberg et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID‐19

(2020) Vui Heng Chong et al.   JOURNAL OF MEDICAL VIROLOGY

ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome

(2020) Christian A. Devaux et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?

(2020) Priyanka Pahan et al.   Journal of Neuroimmune Pharmacology

Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated with Hydroxychloroquine and/or Azithromycin

(2020) David Chang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

(2020) Nicole M Kuderer et al.   LANCET

The many estimates of the COVID-19 case fatality rate

(2020) Dimple D Rajgor et al.   LANCET INFECTIOUS DISEASES

ACUTE QT INTERVAL MODIFICATIONS DURING HYDROXYCHLOROQUINE-AZITHROMYCIN TREATMENT IN THE CONTEXT OF COVID-19 INFECTION.

(2020) Olivier Voisin et al.   MAYO CLINIC PROCEEDINGS

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

(2020) Joshua Geleris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19

(2020) Bo Yu et al.   Science China-Life Sciences

“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers

(2020) Alexandre Gérard et al.   THERAPIE

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France

(2020) Matthieu Million et al.   Travel Medicine and Infectious Disease

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study

(2020) Philippe Gautret et al.   Travel Medicine and Infectious Disease

Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data

(2020) Matthieu Mahévas et al.   BMJ-British Medical Journal

Experience with Hydroxychloroquine and Azithromycin in the COVID‐19 Pandemic: Implications for QT Interval Monitoring

(2020) Archana Ramireddy et al.   Journal of the American Heart Association

Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19

(2020) Mingxing Huang et al.   National Science Review

Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)

(2020) Katelyn A Pastick et al.   Open Forum Infectious Diseases

SARS-CoV-2 genomic variations associated with mortality rate of COVID-19

(2020) Yujiro Toyoshima et al.   JOURNAL OF HUMAN GENETICS

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

(2020) Mayla Gabriela Silva Borba et al.   JAMA Network Open

COVID-19 length of hospital stay: a systematic review and data synthesis

(2020) Eleanor M. Rees et al.   BMC Medicine

COVID-19: Transmission, prevention, and potential therapeutic opportunities

(2020) Melika Lotfi et al.   CLINICA CHIMICA ACTA

Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis

(2020) Zakariya Kashour et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial

(2019) Alexis Mathian et al.   ANNALS OF THE RHEUMATIC DISEASES

Hydroxychloroquine retinopathy — implications of research advances for rheumatology care

(2018) April Jorge et al.   Nature Reviews Rheumatology

SARS and MERS: recent insights into emerging coronaviruses

(2016) Emmie de Wit et al.   NATURE REVIEWS MICROBIOLOGY

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

(2015) Xiang Wan et al.   BMC Medical Research Methodology

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus

(2012) Karim Sacre et al.   ARTHRITIS RESEARCH & THERAPY

Quality Control in Systematic Reviews and Meta-analyses

(2010) M.J. Bown et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY